Publikationen von M. Labeur
Alle Typen
Zeitschriftenartikel (26)
2006
Zeitschriftenartikel
147 (9), S. 4438 - 4444 (2006)
Retinoic acid as a novel medical therapy for Cushing's disease in dogs. Endocrinology
Zeitschriftenartikel
147 (1), S. 247 - 256 (2006)
Bone morphogenetic protein-4 inhibits corticotroph tumor cells: involvement in the retinoic acid inhibitory action. Endocrinology 2004
Zeitschriftenartikel
563 (1-3), S. 229 - 233 (2004)
Nur77 induction and activation are necessary for interleukin-1 stimulation of proopiomelanocortin in AtT-20 corticotrophs. FEBS Letters
Zeitschriftenartikel
4, S. 335 - 342 (2004)
New perspectives in the treatment of Cushing`s Syndrome. Current Drug Targets - Immune, Endocrine & Metabolic Disorders 1995
Zeitschriftenartikel
15, S. 241 - 249 (1995)
TRH receptor on immune cells: in vitro and in vivo stimulation of human lymphocyte and rat splenocyte DNA synthesis. Journal of Clinical Immunology 1994
Zeitschriftenartikel
134, S. 672 - 677 (1994)
Glucocorticoids suppress interleukin-1 receptor antagonist synthesis following induction by endotoxin. Endocrinology Buchkapitel (4)
2010
Buchkapitel
Arzt, E.; Bronstein, M.; Guitelman, M.). Karger, Basel (2010)
Cytokines and Genes in Pituitary Tumorigenesis: RSUME Role in Cell Biology. In: Pituitary Today II: New Molecular, Physiological and Clinical Aspects, S. 1 - 6 (Hg.
Buchkapitel
Arzt, E.; Bronstein, M.; Guitelman, M.). Karger, Basel (2010)
Novel Medical Therapies for Pituitary Tumors. In: Pituitary Today II: New Molecular, Physiological and Clinical Aspects, S. 158 - 164 (Hg. 2006
Buchkapitel
Arzt, E.; Bronstein, M.; Guitelman, M.). KARGER, BASEL (2006)
Bone morphogenetic protein-4 control of pituitary pathophysiology. In: PITUITARY TODAY: MOLECULAR, PHYSIOLOGICAL AND CLINICAL ASPECTS, S. 22 - 31 (Hg.
Buchkapitel
Arzt, E.; Bronstein, M.; Guitelman, M.). KARGER, BASEL (2006)
New aspects in the diagnosis and treatment of Cushing disease. In: PITUITARY TODAY: MOLECULAR, PHYSIOLOGICAL AND CLINICAL ASPECTS, S. 169 - 178 (Hg.